Study Looking at a Drug to Treat Small Cell Lung Cancer

What we are studying

The purpose of this study is to test the safety and effectiveness of an investigational drug when used to treat small cell lung cancer. This drug is thought to kill cancer cells by turning off their mitochondria. Mitochondria are used by cancer cells to produce energy and are the building blocks needed to make more cancer cells.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Histologically or cytologically proven small cell lung cancer that has relapsed or been refractory from one or two lines of chemotherapy

What is involved

  • The length of participation in this study will vary for each person and will be determined by the number of treatment cycles you receive. All participants will be in the study until it is determined that your cancer is no longer responding to treatment with the investigational drug.

Compensation

None

Contact Information

Study Coordinator
Tom Freeman, PA-C
Email
thfreema@wakehealth.edu
Phone
336-713-6914

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.